Talphera, Inc. Common Stock (TLPH)

Price$0.79

Value ScoreA

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-53.64%

Price vs S&P 500 (4W)-16.14%

VGM Score60.95

Market Capitalization$42.35M

All Metrics

Book Value / Share (Quarterly)$0.37

P/TBV (Annual)6.47x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-74.90%

Cash Flow / Share (Quarterly)$-19.92

Price vs S&P 500 (YTD)-39.35%

Gross Margin (TTM)152.49%

Net Profit Margin (TTM)-0.51%

EPS (TTM)$-0.30

10-Day Avg Trading Volume0.13M

EPS Excl Extra (TTM)$-0.30

Revenue Growth (5Y)-65.12%

EPS (Annual)$-0.34

Dividend / Share (Annual)$23.88

ROI (Annual)-83.89%

Gross Margin (Annual)614639.02%

Net Profit Margin (5Y Avg)-10630.61%

Cash / Share (Quarterly)$0.42

ROA (Last FY)-48.08%

Revenue Growth TTM (YoY)5127677.78%

EBITD / Share (TTM)$13.82

ROE (5Y Avg)-250.86%

Operating Margin (TTM)-0.46%

Cash Flow / Share (Annual)$-0.23

P/B Ratio2.29x

P/B Ratio (Quarterly)2.02x

Net Income / Employee (Annual)$-1,190,800

Net Interest Coverage (TTM)61.47x

ROA (TTM)-53.22%

EV / EBITDA (TTM)0.05x

EPS Incl Extra (Annual)$-0.34

Current Ratio (Annual)5.49x

Quick Ratio (Quarterly)5.24x

3-Month Avg Trading Volume0.18M

52-Week Price Return66.50%

Revenue / Employee (TTM)$115,375,000

Tangible BV / Share (Quarterly)$0.19

P/S Ratio (Annual)1512.50x

Asset Turnover (Annual)0.00x

52-Week High$1.57

Operating Margin (5Y Avg)-10970.44%

EPS Excl Extra (Annual)$-0.34

26-Week Price Return-37.71%

Quick Ratio (Annual)5.35x

13-Week Price Return-11.77%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)5.30x

Enterprise Value$38.53M

Revenue / Share Growth (5Y)-77.71%

Asset Turnover (TTM)60.54x

Revenue / Employee (Annual)$2,300

Inventory Turnover (Annual)77.48x

Pretax Margin (Annual)-51296.43%

Cash / Share (Annual)$0.41

3-Month Return Std Dev68.58%

Gross Margin (5Y Avg)122870.11%

Net Income / Employee (TTM)$-1,187,800

ROE (Last FY)-83.89%

Net Interest Coverage (Annual)-12.01x

EPS Basic Excl Extra (Annual)$-0.34

Receivables Turnover (TTM)1.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.30

Receivables Turnover (Annual)0.00x

ROI (TTM)-92.98%

P/S Ratio (TTM)0.03x

Pretax Margin (5Y Avg)-10433.42%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.17

Price vs S&P 500 (52W)38.29%

Year-to-Date Return-28.42%

5-Day Price Return0.11%

EPS Normalized (Annual)$-0.34

ROA (5Y Avg)-30.82%

Net Profit Margin (Annual)-51035.71%

Month-to-Date Return-10.23%

EBITD / Share (Annual)$-0.32

Operating Margin (Annual)-48157.14%

LT Debt / Equity (Annual)173.40x

ROI (5Y Avg)-97.23%

LT Debt / Equity (Quarterly)121.75x

EPS Basic Excl Extra (TTM)$-0.30

P/TBV (Quarterly)3.87x

P/B Ratio (Annual)3.12x

Inventory Turnover (TTM)2.78x

Pretax Margin (TTM)-0.51%

Book Value / Share (Annual)$0.35

Price vs S&P 500 (13W)-21.52%

Beta0.79x

Revenue / Share (TTM)$19.83

ROE (TTM)-92.98%

52-Week Low$0.38

vGradeA

gGradeC

mGradeC

vgmGradeB

Show chart for

Earnings Surprise History

Q1 26-0.04est. -0.07

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.13

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
TLPHTalphera, Inc. Common Stock	A	C	C	$0.79
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
PFEPfizer Inc.	B	C	C	$25.63
ABTAbbott Laboratories	C	C	D	$87.78
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Talphera Inc. is a pharmaceutical company developing therapies for medically supervised clinical settings. Its pipeline centers on nafamostat product candidates, including Niyad and LTX-608, with a focus on pre-filled syringe formulations to optimize drug delivery.